NgoJuni 16-17, 2023, i-MedGence yabamba iqhaza eNgqungqutheleni Yokuthuthukiswa Kwekhwalithi Ephezulu Yemboni Yokunakekelwa Kwezempilo kanye neNgqungquthela yesi-8 ye-China Pharmaceutical R&D Innovation, eyabanjwa ngempumelelo e-Chongqing.
I-MedGence ihlonishwe njengenye ye "2023 Top 20 R&D CRO Enterprises in China"!
Okokuqala, emcimbini wokuvula, uchungechunge lohlu lwe-"2022 China Pharmaceutical R&D Strength Ranking" lwakhululwa futhi i-MedGence yahlonishwa njengomunye "Wama-2023 Top 20 Pharmaceutical CRO Enterprises in China"!
"I-2023 Pharmaceutical CRO Enterprises in China" ikhethwe yi-CRO Ranking Expert Review Committee ngokusekelwe ezinkomba ezingu-10 nobukhulu obuningi, njengesamba semali engenayo yonyaka (imali engenayo yokusebenza), ukukhula kwemali engenayo yonyaka (%), inzuzo yonke, ukukhula kwenzuzo yonke (%), ukutshalwa kwezimali kwe-R&D, ukukhula kokutshalwa kwezimali kwe-R&D (%), usayizi wabasebenzi, ukukhula kosayizi wabasebenzi (%), isibalo sobuholi, kanye nophawu lobuholi be-MG, uphawu lobuholi, nophawu lobuholi, njll. inkampani ehamba phambili yokuthuthukiswa kwemithi entsha ye-TCM ehamba phambili, iwine umklomelo othi “2023 Top 20 Pharmaceutical CRO Enterprises in China”, ikhombise ikhono namandla ayo.
Phakathi naleso sikhathi, njengomholi we-TCM CXO, uDkt. Yi Yueneng, uSihlalo & nomphathi Jikelele we-MedGence, wamenywa ukuba ahlanganyele eNgqungqutheleni Yesishiyagalombili Ye-China Pharmaceutical R&D Innovation futhi wethula inkulumo ethi “Ukuqala Kusukela Ekugcineni - Amasu Okuthuthukiswa Komuthi Omusha WaseShayina”. Uveze ukuthi njengamanje, idizayini esezingeni eliphezulu yokuthuthukiswa kwemithi yamaShayina isheshisiwe futhi yathuthukiswa, indawo yenqubomgomo ithuthukiswe ngokuqhubekayo futhi nokusekelwa kunyusiwe, futhi umuthi waseShayina ungenise inkathi yegolide. Uphinde walungisa isimo senqubomgomo, inqubo yocwaningo kanye nentuthuko, kanye nesimo sokusetshenziswa kokuthuthukiswa kwemboni yemithi yamaShayina enkathini entsha, wabonisa ubudlelwano obunengqondo bangaphakathi, wahlaziya izinkinga ezivelele ezisekhona ekuthuthukisweni kwamanje kwemboni yemithi yendabuko yamaShayina, futhi waphakamisa izindlela zokulwa ezingenzeka.
Khona-ke, uDkt. Yi Yueneng, njengomsingathi wenkundla yezingxoxo ethi “Is the Spring of Chinese Medicine New Product R&D Coming”, ngokuhlanganyela waxoxa ngamathrendi nezinselele ze-R&D kanye nokusungulwa kwemithi yamaShayina nabadlali bemboni. Njengomgqugquzeli oyinhloko, i-MedGence ibilokhu igxile embonini yezemithi, ihlola ngenkuthalo, isungula izinto ezintsha njalo, ikhuthaza ukuthuthukiswa kwemboni, futhi iqhubeka nokusebenzela izinkampani ezithaka imithi kulo lonke elaseChina.
Le ngqungquthela ihehe abaholi abaningi emkhakheni wokulawulwa kwemithi, amakolishi namanyuvesi, izikhungo zocwaningo, izinkampani zemithi, amayunithi e-R & D kanye nabanye abaningi abasezingeni eliphakeme ukuthi babambe iqhaza emibikweni ephathelene ne-R & D yemithi yendabuko yamaShayina, ukwakhiwa emisha, imithetho kanye nezinqubomgomo, ikhwalithi nokuphepha, ukwenziwa ngcono kwenqubo, imishini emisha, ubuchwepheshe obusha kanye nobunye ubuchwepheshe. Abakhiqizi bemithi, njengomunye wabakhangisi abakhethekile balo mcimbi, banedokodo elikhethekile, elihehe inqwaba yozakwabo embonini ukuthi bayivakashele! Phakathi nale ngqungquthela, njengomunye wabakhangisi ababemenyiwe, i-Enable Pharma yayinedokodo elikhethekile, elihehe ozakwabo abaningi bemboni ukuba bavakashele leli dokodo ukuze babonisane, ukuxhumana eduze nezinkampani ezinkulu ezithaka imithi, kanye nesidingo sokumisa ucwaningo nokuthuthukiswa kwezidakamizwa.
Isikhathi sokuthumela: Jul-15-2023